Search results
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 15 hours agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 5 hours agoModerna stock broke out for the first time in a year on Thursday after beating Wall Street's...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 15 hours agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 13 hours agoCash Position: Ended the quarter with $12.2 billion in cash, cash equivalents, and investments, a...
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 10 hours agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year....
Moderna ends gene editing alliance with Metagenomi
BioPharma Dive via Yahoo Finance· 14 hours agoMetagenomi said the companies’ decision to part ways followed a “strategic prioritization” undertaken by Moderna, which has made several investments in...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo News· 15 hours ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 10 hours agoModerna, Inc. MRNA reported earnings of $3.07 per share in the first quarter of 2024, beating the...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 9 hours agoImage source: The Motley Fool. Moderna (NASDAQ: MRNA) Q1 2024 Earnings Call May 02, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 6 hours agoThursday, Moderna Inc MRNA reported a first-quarter EPS loss of $(3.07), down from an income of...